找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Cervical Cancer; Jaime G. de la Garza-Salazar,Flavia Morales-Vásque Book 2017 Springer International Publishing Switzerland 2017 cervical

[復(fù)制鏈接]
樓主: PLY
41#
發(fā)表于 2025-3-28 18:03:43 | 只看該作者
42#
發(fā)表于 2025-3-28 20:33:18 | 只看該作者
43#
發(fā)表于 2025-3-29 00:38:28 | 只看該作者
Cervical Cancer Cytology and Pathology,al/vaginal cytology, including recommendations for a proper cytologic report. Furthermore, the main cytologic criteria used in the diagnosis of squamous and glandular invasive cervical neoplasia precursor lesions are included. In the final part of the cytology section, some advantages and drawbacks
44#
發(fā)表于 2025-3-29 05:27:32 | 只看該作者
45#
發(fā)表于 2025-3-29 10:22:37 | 只看該作者
Imaging in Cervical Cancer,tion of Gynecology and Obstetrics (FIGO) criteria, cancer staging systems have been shown to be deficient for the examination of prognostic factors of CC, including tumor size and infiltration of the parametria or pelvic wall, as well as for the evaluation of nodal metastases. In this regard, imagin
46#
發(fā)表于 2025-3-29 11:55:42 | 只看該作者
47#
發(fā)表于 2025-3-29 18:10:22 | 只看該作者
Surgical Treatment for Advanced or Recurrent Disease in Cervical Cancer,nding on the survival disease-free, the site and size of recurrence can be set 5-year survivals of 48–60%. Since it was first reported in 1948, pelvic exenteration has been used in the treatment of advanced pelvic cancers. The original procedure has been modified in an attempt to preserve urinary or
48#
發(fā)表于 2025-3-29 21:19:26 | 只看該作者
49#
發(fā)表于 2025-3-30 00:32:03 | 只看該作者
50#
發(fā)表于 2025-3-30 04:02:04 | 只看該作者
Immuno-Oncology in Cervical Cancer,une-mediated treatments, or immuno-oncology, currently represent 6% of cancer therapies, and in the next 10 years, this percentage is expected to increase up to 70%. There are ongoing efforts to develop specific immunotherapies, such as immunomodulatory drugs and antibodies, to treat CC in combinati
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 12:36
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
密云县| 宽城| 双鸭山市| 南平市| 贞丰县| 偏关县| 象州县| 江城| 白银市| 恭城| 水富县| 北海市| 临沂市| 尚义县| 辽阳县| 仁布县| 济阳县| 邮箱| 台前县| 玉田县| 比如县| 甘孜县| 龙岩市| 萨嘎县| 建宁县| 当雄县| 友谊县| 新津县| 丹阳市| 乐山市| 永和县| 濮阳市| 古交市| 乐平市| 彭阳县| 潜山县| 澄江县| 安泽县| 棋牌| 哈尔滨市| 奉节县|